Drug Identification and Treatment Method
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,486,926 | Steroid Tetrol Solid State Forms In force · High confidence UsedRemaining | Harbor Therapeutics, Inc. | In force | High confidence | ||
| US 8,354,396 | Drug Identification and Treatment Method In force · High confidence | Neurmedix, Inc. | In force | High confidence | ||
| Application 11/942,689 | Drug Identification and Treatment Method Abandoned Abandoned Aug 26, 2013 | Neurmedix, Inc. | Abandoned | Abandoned Aug 26, 2013 | ||
| Application 13/734,147 | Drug Identification Method Abandoned Abandoned Sep 29, 2014 | Neurmedix, Inc. | Abandoned | Abandoned Sep 29, 2014 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Neurmedix, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.